Pharma-Bio Serv (PBSV) Operating Leases (2020 - 2024)
Historic Operating Leases for Pharma-Bio Serv (PBSV) over the last 7 years, with Q4 2024 value amounting to $28834.0.
- Pharma-Bio Serv's Operating Leases fell 8513.98% to $28834.0 in Q4 2024 from the same period last year, while for Oct 2024 it was $28834.0, marking a year-over-year decrease of 8513.98%. This contributed to the annual value of $28834.0 for FY2024, which is 8513.98% down from last year.
- According to the latest figures from Q4 2024, Pharma-Bio Serv's Operating Leases is $28834.0, which was down 8513.98% from $71362.0 recorded in Q3 2024.
- In the past 5 years, Pharma-Bio Serv's Operating Leases registered a high of $729389.0 during Q1 2020, and its lowest value of $28834.0 during Q4 2024.
- Moreover, its 5-year median value for Operating Leases was $400460.0 (2022), whereas its average is $393144.6.
- As far as peak fluctuations go, Pharma-Bio Serv's Operating Leases crashed by 1841.5% in 2021, and later plummeted by 8513.98% in 2024.
- Pharma-Bio Serv's Operating Leases (Quarter) stood at $629979.0 in 2020, then dropped by 22.64% to $487364.0 in 2021, then fell by 28.9% to $346509.0 in 2022, then plummeted by 44.0% to $194035.0 in 2023, then crashed by 85.14% to $28834.0 in 2024.
- Its last three reported values are $28834.0 in Q4 2024, $71362.0 for Q3 2024, and $113044.0 during Q2 2024.